<DOC>
	<DOCNO>NCT01813916</DOCNO>
	<brief_summary>The purpose study use proteomic analysis synovial fluid perform comprehensive investigation biomarker useful assign tratment effectiveness five weekly intra-articular HA injection .</brief_summary>
	<brief_title>Identification Characterization Biomarker Synovial Fluid Hyaluronic Acid Therapy Osteoarthritis</brief_title>
	<detailed_description>The intra-articular injection HA accept therapy OA . However , exact regulation HA treatment unclear . Compared expression SF proteome OA patient receive HA/800 treatment ( post pre-HA treatment ) may possible identify protein response HA treatment apply prognosis OA . We use two-dimensional difference gel electrophoresis ( 2D-DIGE ) combine matrix-assisted laser desorption ionization time light mass spectrometry ( MALDI-TOF ) determine differentially display protein human SF . Finally , use Western blot ELISA analysis validate potential biomarkers .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Clinical diagnosis osteoarthritis Accept intraarticular HA injection therapy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>synovial fluid</keyword>
	<keyword>hyaluronic acid</keyword>
</DOC>